Does SECUKINUMAB Cause Haemoglobin decreased? 248 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 248 reports of Haemoglobin decreased have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.2% of all adverse event reports for SECUKINUMAB.
248
Reports of Haemoglobin decreased with SECUKINUMAB
0.2%
of all SECUKINUMAB reports
21
Deaths
110
Hospitalizations
How Dangerous Is Haemoglobin decreased From SECUKINUMAB?
Of the 248 reports, 21 (8.5%) resulted in death, 110 (44.4%) required hospitalization, and 24 (9.7%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 248 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which SECUKINUMAB Alternatives Have Lower Haemoglobin decreased Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG